Investigating immune cells that suppress asthma responses to allergens
Allergen-specific lung-resident Tregs in asthma: Targetable suppressors of resident memory Th2 cells
This study is looking at how certain immune cells called regulatory T cells can help manage allergic asthma caused by things we breathe in, with the goal of finding new ways to help asthma patients feel better for a longer time.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Massachusetts General Hospital NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-11008926 on NIH RePORTER |
What this research studies
This research focuses on understanding how specific immune cells, known as regulatory T cells (Tregs), can help control allergic asthma triggered by airborne allergens. The study aims to explore the balance between these Tregs and other immune cells that contribute to asthma symptoms, particularly the Th2 cells that drive inflammation in the lungs. By examining how these Tregs function in the lungs after exposure to allergens, the research seeks to identify new therapeutic strategies that could provide long-lasting relief for asthma patients.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with allergic asthma who experience symptoms triggered by airborne allergens.
Not a fit: Patients with non-allergic asthma or those whose asthma is not influenced by airborne allergens may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to innovative treatments that effectively manage or even cure allergic asthma.
How similar studies have performed: Previous research has shown promise in targeting immune responses in asthma, suggesting that this approach could lead to significant advancements in treatment.
Where this research is happening
Boston, United States
- Massachusetts General Hospital — Boston, United States (Active)
Researchers
- Principal investigator: Luster, Andrew D — Massachusetts General Hospital
- Study coordinator: Luster, Andrew D
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.